Trillium Reports 2015 Financial and Operating Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- US stocks close down as oil spikes 12%, job market weakens
- U.S. nonfarm payroll employment unexpectedly falls in February
- Oracle stock falls on report of scrapped Texas data center plans
- Kuwait cuts oil output as storage fills up
- Boeing reportedly nearing 500-aircraft deal with China ahead of Trump visit
- After-hours movers: Marvell, Samsara, GAP, Cooper Cos.
- After-hours movers: Broadcom, StubHub, Cracker Barrel, Grocery Outlet, Veeva Systems and more
- After-hours movers: Moderna, CrowdStrike, Ross Stores, Box and more
- After-hours movers: MongoDB, Credo, SoFi Technologies and more
- After-hours movers: Dell, Block, CoreWeave, Autodesk, MARA and more
Leerink Partners Remains Bullish as Trillium Therapeutics (TRIL) Continues TTI-621 Development
March 10, 2016 7:48 AM UTCLeerink Partners maintained an Outperform rating on Trillium Therapeutics (NASDAQ: TRIL) price target of $20.00 (from $29.00). Earlier this year TRIL initiated dosing in its Ph I where TTI-621 will be evaluated as a monotherapy in patients with relapsed/refractory hematological malignancies. While TRIL has broadened its portfolio with the recent acquisition of... More
